Sirio Pharma Co., Ltd. (SHE:300791)
25.17
-0.41 (-1.60%)
Jun 18, 2025, 3:04 PM CST
Sirio Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 601.24 | 636.03 | 534.49 | 1,502 | 715.54 | 216.7 | Upgrade
|
Short-Term Investments | - | 25.17 | 20 | 109.26 | - | - | Upgrade
|
Trading Asset Securities | 90.6 | 115.2 | 200.66 | 79.13 | 530.77 | 473.49 | Upgrade
|
Cash & Short-Term Investments | 691.84 | 776.4 | 755.14 | 1,690 | 1,246 | 690.2 | Upgrade
|
Cash Growth | 14.60% | 2.81% | -55.32% | 35.60% | 80.57% | 74.56% | Upgrade
|
Accounts Receivable | 680.22 | 702.53 | 652.86 | 476.96 | 372.33 | 307.1 | Upgrade
|
Other Receivables | 20.88 | 20.81 | 4.99 | 4.45 | 4.27 | 3.13 | Upgrade
|
Receivables | 701.1 | 723.34 | 657.85 | 481.41 | 376.6 | 310.22 | Upgrade
|
Inventory | 537.94 | 481.66 | 481.06 | 232.58 | 239.61 | 266.77 | Upgrade
|
Other Current Assets | 47.02 | 41.54 | 38.87 | 28.58 | 51.99 | 56.64 | Upgrade
|
Total Current Assets | 1,978 | 2,023 | 1,933 | 2,433 | 1,915 | 1,324 | Upgrade
|
Property, Plant & Equipment | 2,094 | 2,093 | 1,913 | 1,332 | 1,173 | 768.05 | Upgrade
|
Long-Term Investments | 215.65 | 52.44 | 94.11 | - | 337.79 | 152.22 | Upgrade
|
Goodwill | 422.69 | 417.1 | 420.73 | 163.05 | 158.59 | 176.28 | Upgrade
|
Other Intangible Assets | 515.19 | 525.92 | 544.84 | 178.33 | 160.75 | 128.97 | Upgrade
|
Long-Term Deferred Tax Assets | 93.79 | 81.36 | 32.48 | 13.75 | 16.31 | 33.75 | Upgrade
|
Long-Term Deferred Charges | 256.1 | 258.14 | 201.92 | 59.45 | 53 | 48.55 | Upgrade
|
Other Long-Term Assets | 38.98 | 34.66 | 55.99 | 7.14 | 6.57 | 17.98 | Upgrade
|
Total Assets | 5,614 | 5,486 | 5,196 | 4,186 | 3,820 | 2,650 | Upgrade
|
Accounts Payable | 380.16 | 393.43 | 398.13 | 259.25 | 195.71 | 199.52 | Upgrade
|
Accrued Expenses | 64.01 | 92.51 | 104.39 | 152.33 | 79.6 | 71.21 | Upgrade
|
Short-Term Debt | 64.7 | 54.82 | - | 0.16 | 0.12 | 1.61 | Upgrade
|
Current Portion of Long-Term Debt | - | 40.59 | 21.25 | - | - | 33.1 | Upgrade
|
Current Portion of Leases | - | 27.09 | 42.8 | 7.26 | 5.19 | - | Upgrade
|
Current Income Taxes Payable | 54.95 | 48.07 | 11.39 | 11.03 | 10.18 | 21.58 | Upgrade
|
Current Unearned Revenue | 42.91 | 36.92 | 53.13 | 25.83 | 28.22 | 43.11 | Upgrade
|
Other Current Liabilities | 267.57 | 131.1 | 120.04 | 13.84 | 13.43 | 16.93 | Upgrade
|
Total Current Liabilities | 874.31 | 824.54 | 751.13 | 469.69 | 332.44 | 387.06 | Upgrade
|
Long-Term Debt | 1,164 | 1,156 | 1,049 | 908.36 | 852.28 | - | Upgrade
|
Long-Term Leases | 326.13 | 328.39 | 256.16 | 21.14 | 16.68 | - | Upgrade
|
Long-Term Unearned Revenue | 57.75 | 59.7 | 65.68 | 62.4 | 61.48 | 65.25 | Upgrade
|
Long-Term Deferred Tax Liabilities | 16.57 | 15.15 | 28.08 | 22.69 | 12.44 | 14.64 | Upgrade
|
Other Long-Term Liabilities | 460.78 | 461.44 | 479.47 | 0.01 | - | - | Upgrade
|
Total Liabilities | 2,900 | 2,845 | 2,630 | 1,484 | 1,275 | 466.94 | Upgrade
|
Common Stock | 237.27 | 235.87 | 181.56 | 180.5 | 180.17 | 120 | Upgrade
|
Additional Paid-In Capital | 520.75 | 500.7 | 547.5 | 1,048 | 1,045 | 1,081 | Upgrade
|
Retained Earnings | 1,691 | 1,623 | 1,496 | 1,278 | 1,138 | 978.14 | Upgrade
|
Treasury Stock | -72.9 | -54.31 | -44.53 | - | - | - | Upgrade
|
Comprehensive Income & Other | 214.72 | 200.88 | 209.37 | 195.13 | 181.35 | 3.75 | Upgrade
|
Total Common Equity | 2,591 | 2,506 | 2,390 | 2,702 | 2,545 | 2,183 | Upgrade
|
Minority Interest | 123.02 | 135.36 | 176.14 | - | 0.01 | 0.01 | Upgrade
|
Shareholders' Equity | 2,714 | 2,641 | 2,566 | 2,702 | 2,545 | 2,183 | Upgrade
|
Total Liabilities & Equity | 5,614 | 5,486 | 5,196 | 4,186 | 3,820 | 2,650 | Upgrade
|
Total Debt | 1,555 | 1,607 | 1,369 | 936.9 | 874.26 | 34.71 | Upgrade
|
Net Cash (Debt) | -863.42 | -830.1 | -614.1 | 753.08 | 372.05 | 655.49 | Upgrade
|
Net Cash Growth | - | - | - | 102.42% | -43.24% | 121.73% | Upgrade
|
Net Cash Per Share | -2.85 | -2.73 | -2.02 | 2.45 | 1.16 | 2.14 | Upgrade
|
Filing Date Shares Outstanding | 304.93 | 306.79 | 304.67 | 305.04 | 304.49 | 304.2 | Upgrade
|
Total Common Shares Outstanding | 304.93 | 304.96 | 304.67 | 305.04 | 304.49 | 304.2 | Upgrade
|
Working Capital | 1,104 | 1,198 | 1,182 | 1,963 | 1,582 | 936.77 | Upgrade
|
Book Value Per Share | 8.50 | 8.22 | 7.84 | 8.86 | 8.36 | 7.18 | Upgrade
|
Tangible Book Value | 1,653 | 1,563 | 1,424 | 2,360 | 2,225 | 1,877 | Upgrade
|
Tangible Book Value Per Share | 5.42 | 5.12 | 4.68 | 7.74 | 7.31 | 6.17 | Upgrade
|
Buildings | - | 1,067 | 1,000 | 890.28 | 528.67 | 478.54 | Upgrade
|
Machinery | - | 1,390 | 1,242 | 974.19 | 773.89 | 645.85 | Upgrade
|
Construction In Progress | - | 238.4 | 186.94 | 69.28 | 365.12 | 117.96 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.